Protein Subunit Vaccines Overview

With extensive capabilities and GMP manufacturing capacity for protein subunit vaccines, WuXi Vaccines offers accelerated end-to-end services from initial cell line development to drug substance (DS), drug product (DP) GMP production and commercial fill finish.

Our GMP facilities, equipped with BSL-1/BSL-2 capability, cover both microbial and mammalian-based manufacturing platforms. We have a world-class quality system and global manufacturing footprint of more than 300K liters in total bioreactor scale, supporting fed-batch and perfusion cell culture processes.

Speed to patients with the highest product quality and safety is core for our success in combating disease including global pandemics. Our state-of-the-art high throughput process development, broad range of analytical toolboxes, highly coordinated CMC development, and deep expertise in developing/manufacturing enable our clients to succeed with both speed and flexibility.

Our broad experience and capacity provide excellence in one-stop shop service spanning early development, late-stage process characterization/validation as well as commercialization.